Register for Newsletter

Startup

Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Bayer awards incubator opportunity to Genvor
Bayer awards incubator opportunity to Genvor
View More

Digitization

Amgen opens new technology and innovation site in Hyderabad
Amgen opens new technology and innovation site in Hyderabad
Indegene launches AI platform Cortex
Indegene launches AI platform Cortex
Utthunga partners with VindAir to advance smart solutions for pharma industry
Utthunga partners with VindAir to advance smart solutions for pharma industry
View More

Latest Stories

Lucas Meyer Cosmetics introduces GlowCytocin to capture the science of “Love Glow”

Indegene launches new center in London

Zota Health Care expands Davaindia network to 1,530 stores

USFDA grants Priority Review for new indication of finerenone for patients with common heart failure

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions

Opinion
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging